1325 / 1816
Axillary lymph nodes and neoadjuvant therapy
• Today’s strategies aim to minimize the rate of patients who undergo
axillary lymph node dissection
•A procedure with low false negative rates is preferred to predict the
axillary status after chemotherapy
SNB: for patients with a clinically negative axilla at time of diagnosis
•
To spare patients from further regional treatment preferred after
NAC